The FDA has accepted for review the NDA for bumetanide nasal spray for edema associated with CHF, as well as hepatic and renal disease.
If you’re interested in a nasal spray for migraine ... You can learn more about how we ensure our content is accurate and current by reading our editorial policy.
The trial will evaluate the safety and effectiveness of a next-generation vaccine administered through a nasal spray or ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback